Virtual Coronary Physiology: an Angiogram is All You Need
Launched by SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST · May 7, 2015
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
1. Plan of Investigation Several interacting workstreams will proceed in parallel in this observational, analytical, 36-month study between the University of Sheffield (UoS), Sheffield Teaching Hospitals NHS Foundation Trust (STH), and our collaborators at King's College London (KCL).
This protocol document outlines the methodology for clinical data collection from patients attending STH. These (fully anonymised) clinical data will then be used to validate and optimise the use of VIRTU by improving its accuracy and speed as well as developing a user-friendly interface. The development w...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Stable symptoms of coronary ischemia
- • Coronary angiographic findings of significant or borderline coronary lesions of any morphology
- • Potentially suitable for PCI
- Exclusion Criteria:
- • Critical ischemia
- • Significant valvular heart disease
- • Bleeding diathesis
- • Terminal cancer
- • Pregnancy 6. Lack of informed consent
- • Chronic total occlusion of target vessel
- • Acute presentation in the previous 60 days
- • Intolerance of adenosine, nitrate, iodine based contrast media
- • Inability to take dual antiplatelet therapy
- • Target vein graft.
About Sheffield Teaching Hospitals Nhs Foundation Trust
Sheffield Teaching Hospitals NHS Foundation Trust is a leading healthcare institution in the UK, dedicated to delivering high-quality patient care, advancing medical research, and fostering education and training in the health sector. As a prominent sponsor of clinical trials, the Trust collaborates with various stakeholders to facilitate innovative research initiatives that aim to improve treatment outcomes and enhance patient safety. With a commitment to excellence, the organization leverages its extensive clinical expertise and resources to support the development of new therapies and interventions, ultimately contributing to the advancement of healthcare practices both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sheffield, , United Kingdom
Sheffield, South Yorkshire, United Kingdom
Patients applied
Trial Officials
Nana Theodorou
Study Chair
STH
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials